Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Segreti

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Critical Care Clinics|January 1, 1989
Nosocomial infections and secondary infections in sepsisJ Segreti
The American Journal of Medicine|December 30, 1991
In vitro activity of temafloxacin against pathogens causing sexually transmitted diseasesJ Segreti
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2009
Empirical therapy for serious Gram-positive infections: making the right choiceJ Segreti
Infectious Disease Clinics of North America|December 1, 1999
Is antibiotic prophylaxis necessary for preventing prosthetic device infection?J Segreti
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2005
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistanceJ Segreti
The American Journal of Medicine|December 30, 1991
Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitisJ Segreti
Disease-A-Month : DM|September 10, 1999
Infectious diarrheaL Goodman, J Segreti
Drugs|January 1, 1995
Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year periodJ Segreti, R Connelly
The American Journal of Medicine|June 24, 1996
Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporinJ Segreti, S Levin
Infectious Disease Clinics of North America|June 1, 1989
The role of prophylactic antibiotics in the prevention of prosthetic device infectionsJ Segreti, S Levin
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Critical Care Clinics|January 1, 1989
Nosocomial infections and secondary infections in sepsisJ Segreti
The American Journal of Medicine|December 30, 1991
In vitro activity of temafloxacin against pathogens causing sexually transmitted diseasesJ Segreti
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 18, 2009
Empirical therapy for serious Gram-positive infections: making the right choiceJ Segreti
Infectious Disease Clinics of North America|December 1, 1999
Is antibiotic prophylaxis necessary for preventing prosthetic device infection?J Segreti
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|April 7, 2005
Efficacy of current agents used in the treatment of Gram-positive infections and the consequences of resistanceJ Segreti
The American Journal of Medicine|December 30, 1991
Fluoroquinolones for the treatment of nongonococcal urethritis/cervicitisJ Segreti
Disease-A-Month : DM|September 10, 1999
Infectious diarrheaL Goodman, J Segreti
Drugs|January 1, 1995
Effect of quinolone use on antimicrobial susceptibility patterns over a 5-year periodJ Segreti, R Connelly
The American Journal of Medicine|June 24, 1996
Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporinJ Segreti, S Levin
Infectious Disease Clinics of North America|June 1, 1989
The role of prophylactic antibiotics in the prevention of prosthetic device infectionsJ Segreti, S Levin
Pageof 5